Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 1 | Journal of Translational Medicine

Fig. 1

From: Acute canagliflozin treatment protects against in vivo myocardial ischemia–reperfusion injury in non-diabetic male rats and enhances endothelium-dependent vasorelaxation

Fig. 1

Measurement of myocardial infarct size and serum troponin-T. Myocardial infarct size of vehicle-treated (IRI, n = 7) and canagliflozin-treated (IRI + cana, n = 7) rats with myocardial infarction is depicted as percentage of area at risk. Area at risk (the area distal to the occlusion) is expressed as the percentage of the total ventricular area in each group. Serum troponin-T values of these groups are depicted. Student t-test P values are reported with ticked lines between two groups. cana canagliflozin, IRI ischemia–reperfusion injury

Back to article page